Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials
根据 IMDC 风险分组对转移性透明细胞肾细胞癌患者进行免疫检查点抑制剂治疗方案的持久疗效进行分析:一项汇总分析了四项随机 3 期试验
期刊:Kidney Cancer
影响因子:1.100
doi:10.1177/24684570241311419
Jang, Albert; Zhong, Jeffrey Y; Kumar, Hamsa L S; Zarrabi, Kevin K; Zhu, Alec; Grier, Abby L; Calaway, Adam; Shoag, Jonathan E; Bukavina, Laura; Jia, Angela Y; Mendiratta, Prateek; Sheng, Iris Y; Rao, Santosh; Brown, Jason R; Garcia, Jorge A; Margevicius, Seunghee; Fu, Pingfu; Barata, Pedro C